A SGLT2 Inhibitor Dapagliflozin Alleviates Diabetic Cardiomyopathy by Suppressing High Glucose-Induced Oxidative Stress in vivo and in vitro
SGLT2抑制剂达格列净可通过抑制体内外高糖诱导的氧化应激来缓解糖尿病心肌病
期刊:Frontiers in Pharmacology
影响因子:4.8
doi:10.3389/fphar.2021.708177
Xing, Yu-Jie; Liu, Biao-Hu; Wan, Shu-Jun; Cheng, Yi; Zhou, Si-Min; Sun, Yue; Yao, Xin-Ming; Hua, Qiang; Meng, Xiang-Jian; Cheng, Jin-Han; Zhong, Min; Zhang, Yan; Lv, Kun; Kong, Xiang